Related Experiment Video
Updated: Jun 28, 2026
06:23
A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
Published on: January 12, 2017
Screening for bladder cancer using urine-based tumor markers
R S Svatek1, Y Lotan, P I Karakiewizc
1Department of Urologic Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Summary
Bladder cancer screening using urine markers shows promise for early detection, potentially reducing mortality. However, widespread adoption requires evidence of effectiveness and careful financial consideration.
Area of Science:
- Urology
- Oncology
- Biomarker Discovery
Background:
- Bladder cancer screening aims to reduce mortality by detecting disease early, before symptoms arise.
- Urothelial carcinoma of the bladder presents unique opportunities for screening due to a defined target population and survival rates linked to early stage detection.
Purpose of the Study:
- To review the current literature on bladder cancer screening utilizing urine-based markers.
- To evaluate the potential of urine markers for early detection of urothelial carcinoma.
Main Methods:
- Literature review of studies investigating urine-based markers for bladder cancer detection.
- Analysis of the biological basis and diagnostic potential of identified urine markers.
Main Results:
- Recent advancements in understanding bladder cancer biology have led to the identification of promising urine-based markers.
- Theoretical feasibility of quick, easy, and painless screening tests using tumor markers is supported by direct cancer cell exposure to urine.
Conclusions:
- While promising urine-based markers exist for bladder cancer detection, widespread screening program adoption is cautioned against without established evidence of effectiveness.
- Large-scale financial implications and the need for robust evidence are critical considerations before implementing bladder cancer screening programs.
